Chronic rhinosinusitis treatment
Pro Research Analysisby 
Searched over 200M research papers
Chronic Rhinosinusitis Treatment: Current Insights and Approaches
Introduction to Chronic Rhinosinusitis (CRS)
Chronic rhinosinusitis (CRS) is a prevalent condition characterized by prolonged inflammation of the nasal and sinus linings, leading to symptoms such as nasal blockage, rhinorrhea, facial pain, and loss of smell. CRS can occur with or without nasal polyps (CRSwNP or CRSsNP) and affects a significant portion of the population .
Medical Interventions for CRS in Cystic Fibrosis
In individuals with cystic fibrosis, CRS is a common complication. Various medical interventions, including nasal saline irrigations, corticosteroids, antibiotics, and CFTR modulators, have been explored. However, the efficacy of these treatments remains unclear due to a lack of high-quality trials .
Short-Course Oral Steroids as Adjunct Therapy
Short courses of oral corticosteroids, when used alongside standard treatments like intranasal corticosteroids or antibiotics, may offer benefits in reducing symptom severity and polyp size in CRS patients. However, the evidence supporting these benefits is of low quality, and the long-term effects and potential adverse events remain uncertain .
Biologics for Severe CRS with Nasal Polyps
Biologics, such as monoclonal antibodies, have shown promise in treating severe CRS with nasal polyps. Dupilumab, mepolizumab, and omalizumab have been evaluated, with dupilumab demonstrating significant improvements in disease-specific quality of life, symptom severity, and reduction in the need for surgery. Mepolizumab and omalizumab also show potential benefits, but the evidence is less certain 358.
Surgical Therapy vs. Continued Medical Therapy
For patients with CRS refractory to medical therapy, surgery is often considered. A systematic review and meta-analysis suggest that surgery may offer benefits over continued medical therapy, but the evidence is not definitive, and further research is needed to establish clear guidelines .
Antifungal Treatments
The use of antifungal treatments, both topical and systemic, for CRS has been explored with mixed results. Intranasal amphotericin B showed some promise in reducing mucosal thickening and improving endoscopic scores, but the overall evidence for antifungal efficacy in CRS is very low, and further studies are required 910.
Utilizing Endotypes, Phenotypes, and Inflammatory Markers
Advancements in understanding the inflammatory endotypes and phenotypes of CRS have opened the door to more personalized treatment approaches. Identifying specific biomarkers can help tailor therapies to individual patients, although clinically validated tools for this purpose are still lacking .
Conclusion
The treatment of chronic rhinosinusitis involves a multifaceted approach, including medical therapies, biologics, and potentially surgery for refractory cases. While some treatments show promise, the quality of evidence varies, and more high-quality research is needed to establish definitive treatment protocols. Personalized treatment based on endotypes and biomarkers represents a future direction for improving patient outcomes in CRS.
Sources and full results
Most relevant research papers on this topic
Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.
Biologics can effectively treat nasal polyps, reducing polyp size and disease severity, and improving sense of smell and quality of life, but more research is needed.
Utilizing Endotypes, Phenotypes, and Inflammatory Markers to Guide Treatment Decisions in Chronic Rhinosinusitis.
Additional studies are needed to determine if endotypes, phenotypes, and biomarkers can guide individualized treatment decisions for Chronic Rhinosinusitis patients.
DOI